Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp > JDRF tweeting about Sernova
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(160)
•••
Post by Redbaron2211on Jan 25, 2021 9:43pm
380 Views
Post# 32382728

JDRF tweeting about Sernova

JDRF tweeting about SernovaWow thats some validation!  Nice, I wouldnt be suprised to see more JDRF funding incoming.    

For those that dont follow them on Twitter;


JDRF Canada
Posted 13:54 24 Jan 2021

@TweeterDee16 We too are excited by Sernova’s progress in the area of cell therapies for T1D! We have been supporting them since 2016 & continue to provide funding for the ongoing clinical trial. We look forward to reporting back to the community about more progress from Sernova in the future!
 

JDRF is so proud to be a significant funder of this clinical trial, as we mark the centenary of the discovery of insulin this year. It is through investments in this type of research that we will move #beyondinsulin and accelerate towards a cure. https://t.co/J9puvT40Kn

theglobeandmail.com/business/artic…


 


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities